SCHEMBL29097820

SCHEMBL29097820

CC(C)(C)OC(=O)N1CCc2ccc(COc3ccc(Cl)cc3F)cc2C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR2 Q92731 2/20 0.53
▸ NR1H2 P55055 1/20 0.53
▸ MRGPRX4 Q96LA9 2/20 0.44
▸ MKNK1 Q9BUB5 1/20 0.44
▸ USP30 Q70CQ3 1/20 0.41
▸ HPGD P15428 3/20 0.41
▸ USP2 O75604 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ CYP3A5 P20815 2/20 0.41
▸ PTGDR2 Q9Y5Y4 4/20 0.40
▸ CHRM4 P08173 1/20 0.40
▸ GPR119 Q8TDV5 1/20 0.39
▸ CYP4F2 P78329 1/20 0.39
▸ CYP4A11 Q02928 1/20 0.39
▸ ACACB O00763 1/20 0.39
▸ ESR1 P03372 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30199299 1.00 ESR2 (0.53) ESR2NR1H2MRGPRX4MKNK1USP30
SCHEMBL29097943 0.86 MRGPRX4 (0.52) ESR2MRGPRX4HPGDUSP2MAPT
SCHEMBL30474270 0.85 NR1H2 (0.54) ESR2NR1H2MKNK1USP30HTT
SCHEMBL30198885 0.83 ESR2 (0.53) ESR2NR1H2GPR119CYP4F2CYP4A11
SCHEMBL30199620 0.83 ESR2 (0.53) ESR2NR1H2GPR119CYP4F2CYP4A11
SCHEMBL29097963 0.83 ESR2 (0.53) ESR2NR1H2GPR119CYP4F2CYP4A11
SCHEMBL29388008 0.81 NR1H2 (0.72) ESR2NR1H2MKNK1MAPTESR1
SCHEMBL30199070 0.81 ESR2 (0.58) ESR2NR1H2MAPTGPR119
SCHEMBL29097838 0.81 ESR2 (0.58) ESR2NR1H2MAPTGPR119
SCHEMBL30199177 0.81 ESR2 (0.53) ESR2NR1H2GPR119CYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115594669-A Fused ring derivative and preparation method and medical application thereof 深圳信立泰药业股份有限公司(CN) 2023-01-13 — — CN disclosed
Send feedback